We are live on ! Find out more
KRON

Kronos Bio

Delisted

KRON was delisted on the 20th of June, 2025.

81 hedge funds and large institutions have $558M invested in Kronos Bio in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

4% more ownership

Funds ownership: 68.84%72.84% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

2% less funds holding

Funds holding: 8381 (-2)

31% less capital invested

Capital invested by funds: $812M → $558M (-$254M)

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
30
Reduced
16
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$438K +$504K +32,230 New
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$409K +$470K +30,063 New
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$381K -$1.02K -65 -0.2%
Bank of America
54
Bank of America
North Carolina
$349K +$200K +12,794 +100%
Two Sigma Advisers
55
Two Sigma Advisers
New York
$287K +$330K +21,100 New
AIG
56
American International Group
New York
$280K -$9.67K -618 -3%
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$242K +$191K +12,236 +221%
Wells Fargo
58
Wells Fargo
California
$226K +$192K +12,246 +279%
ProShare Advisors
59
ProShare Advisors
Maryland
$223K +$257K +16,419 New
NW
60
NewEdge Wealth
Pennsylvania
$220K +$90.3K +5,773 +55%
Renaissance Technologies
61
Renaissance Technologies
New York
$211K +$242K +15,500 New
MIM
62
MetLife Investment Management
New Jersey
$210K
VOYA Investment Management
63
VOYA Investment Management
Georgia
$205K -$125 -8 -0.1%
HighTower Advisors
64
HighTower Advisors
Illinois
$204K
CS
65
Credit Suisse
Switzerland
$187K -$368K -23,529 -63%
Invesco
66
Invesco
Georgia
$186K -$2.67K -171 -1%
VEA
67
Virtus ETF Advisers
New York
$171K +$69.2K +4,422 +54%
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
$161K
PPA
69
Parametric Portfolio Associates
Washington
$139K -$109K -6,951 -40%
Handelsbanken Fonder
70
Handelsbanken Fonder
Sweden
$137K
Legal & General Group
71
Legal & General Group
United Kingdom
$109K
TRCT
72
Tower Research Capital (TRC)
New York
$54K +$47.2K +3,017 +312%
AIP
73
Ameritas Investment Partners
Nebraska
$41K
QT
74
Quantbot Technologies
New York
$36K +$42.2K +2,700 New
National Bank of Canada
75
National Bank of Canada
Quebec, Canada
$13K +$14.9K +950 New

KRON Hedge Fund Activity: Q4 2021 in Review

81 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2021, worth a combined $558M — down 31% from $812M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of KRON and 12 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 30 added.

The largest buyer was State Street, adding an estimated $12.9M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $18.8M sold.

  • 81 institutional investors held Kronos Bio (KRON) as of Q4 2021, down from 83 in Q3 2021.
  • Funds reported $558M of Kronos Bio stock for Q4 2021, down 31% quarter-over-quarter.
  • 12 funds opened new Kronos Bio positions in Q4 2021 and 13 closed out, a net change of -1 holder.
  • The largest Kronos Bio buyer in Q4 2021 was State Street, an estimated $12.9M added.
  • The largest Kronos Bio seller in Q4 2021 was Capital Research Global Investors, an estimated $18.8M sold.

Based on aggregated 13F filings for Q4 2021.